Custom Antibody Services Market By Service (Antibody Development, Antibody Production and Purification, Antibody Fragmentation and Labeling) , By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Others) By Source (Mice, Rabbit,
Description
Custom Antibody Services Market By Service (Antibody Development, Antibody Production and Purification, Antibody Fragmentation and Labeling) , By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Others) By Source (Mice, Rabbit, Others) By Application (Oncology, Infectious Diseases, Neurology, Immunology, Cardiovascular Diseases, Others) By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Custom Antibody Services Market
The custom antibody services market was valued at $0.6 billion in 2023 and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
Custom antibody services involve producing distinguished antibodies as per user requirements. The antibodies are specifically tailored for diagnostic, research, and therapeutic purposes. A key benefit of utilizing custom antibody services is the attainability of specificity in antibodies against antigens, resulting in improved & reliable experimental results. In addition, the flexibility of integrating different modifications into the antibodies attracts clients to benefit from the custom antibody services.
Increase in the popularity of personalized medicine for targeted therapies is rising the adoption of custom antibody services in the healthcare field. In addition, with surging expenditure in the pharmaceutical and biotech sectors for the strengthening of their R&D activities, the growth of the market is being driven considerably. The future of the custom antibody services market is anticipated to be redefined by recombinant technology and novel antibody trends. AI and ML algorithm are poised to assist in the designing of antibodies and develop next-generational antibodies such as single domain antibodies, bispecific antibodies, and antibody fragments.
However, the high cost of antibody production and extended development time hamper the growth of the custom antibody services market. In addition, the quality control measures and validation processes established for the approval of antibodies are highly rigorous and time-consuming. Efficient compliance with such standards delays the growth of the market. Contrarily, with rising investments on drug development and R&D, the custom antibody services market is anticipated to witness several lucrative growth opportunities. According to Statista, a global data and business intelligence platform, the U.S. spent an estimated amount of $603 billion on medicine in 2022. Furthermore, pharma companies in the U.S. spend approximately 21% of their revenue on R&D activities. Such expenditures indicate a promising future for the custom antibody services market.
Segment Review
The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of service, the market is divided into antibody development, antibody production & purification, and antibody fragmentation & labeling. As per type, it is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. Depending on source, it is categorized into mice, rabbit, and others. According to application, it is divided into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of service, the antibody development segment dominated the market in 2023.
As per type, the monoclonal antibodies segment was the major shareholder of the market in 2023.
Depending on source, the rabbit segment held a high share in the market in 2023.
According to application, the infectious diseases segment accounted for a high share in the market in 2023.
By end user, the pharmaceutical & biotechnology companies segment acquired a high stake in the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players of the global custom antibody services market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc., Laboratory Corporation of America Holdings., and GenScript. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.
Key Market Segments
By Service
Antibody Development
Antibody Production and Purification
Antibody Fragmentation and Labeling
By Type
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Others
By Source
Mice
Rabbit
Others
By Application
Oncology
Infectious Diseases
Neurology
Immunology
Cardiovascular Diseases
Others
By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
Sino Biological, Inc.
Bio-Rad Laboratories, Inc
Kaneka Eurogentec S.A.
YenZym Antibodies, LLC.
OriGene Technologies, Inc.
Laboratory Corporation of America Holdings.
GenScript
Table of Contents
233 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Service
- 4.2. Antibody Development
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Antibody Production And Purification
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Antibody Fragmentation And Labeling
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: CUSTOM ANTIBODY SERVICES MARKET, BY TYPE
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Type
- 5.2. Monoclonal Antibodies
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Polyclonal Antibodies
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Recombinant Antibodies
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Source
- 6.2. Mice
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Rabbit
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Application
- 7.2. Oncology
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
- 7.3. Infectious Diseases
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
- 7.4. Neurology
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
- 7.5. Immunology
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
- 7.6. Cardiovascular Diseases
- 7.6.1. Key Market Trends, Growth Factors and Opportunities
- 7.6.2. Market Size and Forecast, By Region
- 7.6.3. Market Share Analysis, By Country
- 7.7. Others
- 7.7.1. Key Market Trends, Growth Factors and Opportunities
- 7.7.2. Market Size and Forecast, By Region
- 7.7.3. Market Share Analysis, By Country
- CHAPTER 8: CUSTOM ANTIBODY SERVICES MARKET, BY END USER
- 8.1. Market Overview
- 8.1.1 Market Size and Forecast, By End User
- 8.2. Pharmaceutical And Biotechnology Companies
- 8.2.1. Key Market Trends, Growth Factors and Opportunities
- 8.2.2. Market Size and Forecast, By Region
- 8.2.3. Market Share Analysis, By Country
- 8.3. Academic And Research Institutes
- 8.3.1. Key Market Trends, Growth Factors and Opportunities
- 8.3.2. Market Size and Forecast, By Region
- 8.3.3. Market Share Analysis, By Country
- 8.4. Others
- 8.4.1. Key Market Trends, Growth Factors and Opportunities
- 8.4.2. Market Size and Forecast, By Region
- 8.4.3. Market Share Analysis, By Country
- CHAPTER 9: CUSTOM ANTIBODY SERVICES MARKET, BY REGION
- 9.1. Market Overview
- 9.1.1 Market Size and Forecast, By Region
- 9.2. North America
- 9.2.1. Key Market Trends and Opportunities
- 9.2.2. Market Size and Forecast, By Service
- 9.2.3. Market Size and Forecast, By Type
- 9.2.4. Market Size and Forecast, By Source
- 9.2.5. Market Size and Forecast, By Application
- 9.2.6. Market Size and Forecast, By End User
- 9.2.7. Market Size and Forecast, By Country
- 9.2.8. U.S. Custom Antibody Services Market
- 9.2.8.1. Market Size and Forecast, By Service
- 9.2.8.2. Market Size and Forecast, By Type
- 9.2.8.3. Market Size and Forecast, By Source
- 9.2.8.4. Market Size and Forecast, By Application
- 9.2.8.5. Market Size and Forecast, By End User
- 9.2.9. Canada Custom Antibody Services Market
- 9.2.9.1. Market Size and Forecast, By Service
- 9.2.9.2. Market Size and Forecast, By Type
- 9.2.9.3. Market Size and Forecast, By Source
- 9.2.9.4. Market Size and Forecast, By Application
- 9.2.9.5. Market Size and Forecast, By End User
- 9.2.10. Mexico Custom Antibody Services Market
- 9.2.10.1. Market Size and Forecast, By Service
- 9.2.10.2. Market Size and Forecast, By Type
- 9.2.10.3. Market Size and Forecast, By Source
- 9.2.10.4. Market Size and Forecast, By Application
- 9.2.10.5. Market Size and Forecast, By End User
- 9.3. Europe
- 9.3.1. Key Market Trends and Opportunities
- 9.3.2. Market Size and Forecast, By Service
- 9.3.3. Market Size and Forecast, By Type
- 9.3.4. Market Size and Forecast, By Source
- 9.3.5. Market Size and Forecast, By Application
- 9.3.6. Market Size and Forecast, By End User
- 9.3.7. Market Size and Forecast, By Country
- 9.3.8. Germany Custom Antibody Services Market
- 9.3.8.1. Market Size and Forecast, By Service
- 9.3.8.2. Market Size and Forecast, By Type
- 9.3.8.3. Market Size and Forecast, By Source
- 9.3.8.4. Market Size and Forecast, By Application
- 9.3.8.5. Market Size and Forecast, By End User
- 9.3.9. France Custom Antibody Services Market
- 9.3.9.1. Market Size and Forecast, By Service
- 9.3.9.2. Market Size and Forecast, By Type
- 9.3.9.3. Market Size and Forecast, By Source
- 9.3.9.4. Market Size and Forecast, By Application
- 9.3.9.5. Market Size and Forecast, By End User
- 9.3.10. UK Custom Antibody Services Market
- 9.3.10.1. Market Size and Forecast, By Service
- 9.3.10.2. Market Size and Forecast, By Type
- 9.3.10.3. Market Size and Forecast, By Source
- 9.3.10.4. Market Size and Forecast, By Application
- 9.3.10.5. Market Size and Forecast, By End User
- 9.3.11. Italy Custom Antibody Services Market
- 9.3.11.1. Market Size and Forecast, By Service
- 9.3.11.2. Market Size and Forecast, By Type
- 9.3.11.3. Market Size and Forecast, By Source
- 9.3.11.4. Market Size and Forecast, By Application
- 9.3.11.5. Market Size and Forecast, By End User
- 9.3.12. Spain Custom Antibody Services Market
- 9.3.12.1. Market Size and Forecast, By Service
- 9.3.12.2. Market Size and Forecast, By Type
- 9.3.12.3. Market Size and Forecast, By Source
- 9.3.12.4. Market Size and Forecast, By Application
- 9.3.12.5. Market Size and Forecast, By End User
- 9.3.13. Rest Of Europe Custom Antibody Services Market
- 9.3.13.1. Market Size and Forecast, By Service
- 9.3.13.2. Market Size and Forecast, By Type
- 9.3.13.3. Market Size and Forecast, By Source
- 9.3.13.4. Market Size and Forecast, By Application
- 9.3.13.5. Market Size and Forecast, By End User
- 9.4. Asia-Pacific
- 9.4.1. Key Market Trends and Opportunities
- 9.4.2. Market Size and Forecast, By Service
- 9.4.3. Market Size and Forecast, By Type
- 9.4.4. Market Size and Forecast, By Source
- 9.4.5. Market Size and Forecast, By Application
- 9.4.6. Market Size and Forecast, By End User
- 9.4.7. Market Size and Forecast, By Country
- 9.4.8. Japan Custom Antibody Services Market
- 9.4.8.1. Market Size and Forecast, By Service
- 9.4.8.2. Market Size and Forecast, By Type
- 9.4.8.3. Market Size and Forecast, By Source
- 9.4.8.4. Market Size and Forecast, By Application
- 9.4.8.5. Market Size and Forecast, By End User
- 9.4.9. China Custom Antibody Services Market
- 9.4.9.1. Market Size and Forecast, By Service
- 9.4.9.2. Market Size and Forecast, By Type
- 9.4.9.3. Market Size and Forecast, By Source
- 9.4.9.4. Market Size and Forecast, By Application
- 9.4.9.5. Market Size and Forecast, By End User
- 9.4.10. India Custom Antibody Services Market
- 9.4.10.1. Market Size and Forecast, By Service
- 9.4.10.2. Market Size and Forecast, By Type
- 9.4.10.3. Market Size and Forecast, By Source
- 9.4.10.4. Market Size and Forecast, By Application
- 9.4.10.5. Market Size and Forecast, By End User
- 9.4.11. Australia Custom Antibody Services Market
- 9.4.11.1. Market Size and Forecast, By Service
- 9.4.11.2. Market Size and Forecast, By Type
- 9.4.11.3. Market Size and Forecast, By Source
- 9.4.11.4. Market Size and Forecast, By Application
- 9.4.11.5. Market Size and Forecast, By End User
- 9.4.12. South Korea Custom Antibody Services Market
- 9.4.12.1. Market Size and Forecast, By Service
- 9.4.12.2. Market Size and Forecast, By Type
- 9.4.12.3. Market Size and Forecast, By Source
- 9.4.12.4. Market Size and Forecast, By Application
- 9.4.12.5. Market Size and Forecast, By End User
- 9.4.13. Rest of Asia-Pacific Custom Antibody Services Market
- 9.4.13.1. Market Size and Forecast, By Service
- 9.4.13.2. Market Size and Forecast, By Type
- 9.4.13.3. Market Size and Forecast, By Source
- 9.4.13.4. Market Size and Forecast, By Application
- 9.4.13.5. Market Size and Forecast, By End User
- 9.5. LAMEA
- 9.5.1. Key Market Trends and Opportunities
- 9.5.2. Market Size and Forecast, By Service
- 9.5.3. Market Size and Forecast, By Type
- 9.5.4. Market Size and Forecast, By Source
- 9.5.5. Market Size and Forecast, By Application
- 9.5.6. Market Size and Forecast, By End User
- 9.5.7. Market Size and Forecast, By Country
- 9.5.8. Brazil Custom Antibody Services Market
- 9.5.8.1. Market Size and Forecast, By Service
- 9.5.8.2. Market Size and Forecast, By Type
- 9.5.8.3. Market Size and Forecast, By Source
- 9.5.8.4. Market Size and Forecast, By Application
- 9.5.8.5. Market Size and Forecast, By End User
- 9.5.9. Saudi Arabia Custom Antibody Services Market
- 9.5.9.1. Market Size and Forecast, By Service
- 9.5.9.2. Market Size and Forecast, By Type
- 9.5.9.3. Market Size and Forecast, By Source
- 9.5.9.4. Market Size and Forecast, By Application
- 9.5.9.5. Market Size and Forecast, By End User
- 9.5.10. South Africa Custom Antibody Services Market
- 9.5.10.1. Market Size and Forecast, By Service
- 9.5.10.2. Market Size and Forecast, By Type
- 9.5.10.3. Market Size and Forecast, By Source
- 9.5.10.4. Market Size and Forecast, By Application
- 9.5.10.5. Market Size and Forecast, By End User
- 9.5.11. Rest of LAMEA Custom Antibody Services Market
- 9.5.11.1. Market Size and Forecast, By Service
- 9.5.11.2. Market Size and Forecast, By Type
- 9.5.11.3. Market Size and Forecast, By Source
- 9.5.11.4. Market Size and Forecast, By Application
- 9.5.11.5. Market Size and Forecast, By End User
- CHAPTER 10: COMPETITIVE LANDSCAPE
- 10.1. Introduction
- 10.2. Top Winning Strategies
- 10.3. Product Mapping Of Top 10 Player
- 10.4. Competitive Dashboard
- 10.5. Competitive Heatmap
- 10.6. Top Player Positioning, 2023
- CHAPTER 11: COMPANY PROFILES
- 11.1. Thermo Fisher Scientific Inc.
- 11.1.1. Company Overview
- 11.1.2. Key Executives
- 11.1.3. Company Snapshot
- 11.1.4. Operating Business Segments
- 11.1.5. Product Portfolio
- 11.1.6. Business Performance
- 11.1.7. Key Strategic Moves and Developments
- 11.2. Merck KGaA
- 11.2.1. Company Overview
- 11.2.2. Key Executives
- 11.2.3. Company Snapshot
- 11.2.4. Operating Business Segments
- 11.2.5. Product Portfolio
- 11.2.6. Business Performance
- 11.2.7. Key Strategic Moves and Developments
- 11.3. Agilent Technologies, Inc.
- 11.3.1. Company Overview
- 11.3.2. Key Executives
- 11.3.3. Company Snapshot
- 11.3.4. Operating Business Segments
- 11.3.5. Product Portfolio
- 11.3.6. Business Performance
- 11.3.7. Key Strategic Moves and Developments
- 11.4. Sino Biological, Inc.
- 11.4.1. Company Overview
- 11.4.2. Key Executives
- 11.4.3. Company Snapshot
- 11.4.4. Operating Business Segments
- 11.4.5. Product Portfolio
- 11.4.6. Business Performance
- 11.4.7. Key Strategic Moves and Developments
- 11.5. Bio-Rad Laboratories, Inc
- 11.5.1. Company Overview
- 11.5.2. Key Executives
- 11.5.3. Company Snapshot
- 11.5.4. Operating Business Segments
- 11.5.5. Product Portfolio
- 11.5.6. Business Performance
- 11.5.7. Key Strategic Moves and Developments
- 11.6. Kaneka Eurogentec S.A.
- 11.6.1. Company Overview
- 11.6.2. Key Executives
- 11.6.3. Company Snapshot
- 11.6.4. Operating Business Segments
- 11.6.5. Product Portfolio
- 11.6.6. Business Performance
- 11.6.7. Key Strategic Moves and Developments
- 11.7. YenZym Antibodies, LLC.
- 11.7.1. Company Overview
- 11.7.2. Key Executives
- 11.7.3. Company Snapshot
- 11.7.4. Operating Business Segments
- 11.7.5. Product Portfolio
- 11.7.6. Business Performance
- 11.7.7. Key Strategic Moves and Developments
- 11.8. OriGene Technologies, Inc.
- 11.8.1. Company Overview
- 11.8.2. Key Executives
- 11.8.3. Company Snapshot
- 11.8.4. Operating Business Segments
- 11.8.5. Product Portfolio
- 11.8.6. Business Performance
- 11.8.7. Key Strategic Moves and Developments
- 11.9. Laboratory Corporation Of America Holdings.
- 11.9.1. Company Overview
- 11.9.2. Key Executives
- 11.9.3. Company Snapshot
- 11.9.4. Operating Business Segments
- 11.9.5. Product Portfolio
- 11.9.6. Business Performance
- 11.9.7. Key Strategic Moves and Developments
- 11.10. GenScript
- 11.10.1. Company Overview
- 11.10.2. Key Executives
- 11.10.3. Company Snapshot
- 11.10.4. Operating Business Segments
- 11.10.5. Product Portfolio
- 11.10.6. Business Performance
- 11.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 2. CUSTOM ANTIBODY SERVICES MARKET FOR ANTIBODY DEVELOPMENT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. CUSTOM ANTIBODY SERVICES MARKET FOR ANTIBODY PRODUCTION AND PURIFICATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. CUSTOM ANTIBODY SERVICES MARKET FOR ANTIBODY FRAGMENTATION AND LABELING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. GLOBAL CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 6. CUSTOM ANTIBODY SERVICES MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. CUSTOM ANTIBODY SERVICES MARKET FOR POLYCLONAL ANTIBODIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. CUSTOM ANTIBODY SERVICES MARKET FOR RECOMBINANT ANTIBODIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. CUSTOM ANTIBODY SERVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. GLOBAL CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 11. CUSTOM ANTIBODY SERVICES MARKET FOR MICE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. CUSTOM ANTIBODY SERVICES MARKET FOR RABBIT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. CUSTOM ANTIBODY SERVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. GLOBAL CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 15. CUSTOM ANTIBODY SERVICES MARKET FOR ONCOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. CUSTOM ANTIBODY SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. CUSTOM ANTIBODY SERVICES MARKET FOR NEUROLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 18. CUSTOM ANTIBODY SERVICES MARKET FOR IMMUNOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 19. CUSTOM ANTIBODY SERVICES MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 20. CUSTOM ANTIBODY SERVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 21. GLOBAL CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. CUSTOM ANTIBODY SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 23. CUSTOM ANTIBODY SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 24. CUSTOM ANTIBODY SERVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 25. CUSTOM ANTIBODY SERVICES MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 26. NORTH AMERICA CUSTOM ANTIBODY SERVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 27. NORTH AMERICA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 28. NORTH AMERICA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 29. NORTH AMERICA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 30. NORTH AMERICA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 31. NORTH AMERICA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. U.S. CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 33. U.S. CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 34. U.S. CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 35. U.S. CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 36. U.S. CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. CANADA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 38. CANADA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 39. CANADA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 40. CANADA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 41. CANADA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. MEXICO CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 43. MEXICO CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 44. MEXICO CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 45. MEXICO CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 46. MEXICO CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 48. EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 49. EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 50. EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 51. EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 52. EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 53. GERMANY CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 54. GERMANY CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. GERMANY CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 56. GERMANY CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 57. GERMANY CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. FRANCE CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 59. FRANCE CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 60. FRANCE CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 61. FRANCE CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 62. FRANCE CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. UK CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 64. UK CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 65. UK CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 66. UK CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 67. UK CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 68. ITALY CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 69. ITALY CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 70. ITALY CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 71. ITALY CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 72. ITALY CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 73. SPAIN CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 74. SPAIN CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 75. SPAIN CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 76. SPAIN CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 77. SPAIN CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 78. REST OF EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 79. REST OF EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 80. REST OF EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 81. REST OF EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 82. REST OF EUROPE CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 84. ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 85. ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 86. ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 87. ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 88. ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 89. JAPAN CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 90. JAPAN CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 91. JAPAN CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 92. JAPAN CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 93. JAPAN CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 94. CHINA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 95. CHINA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 96. CHINA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 97. CHINA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 98. CHINA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 99. INDIA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 100. INDIA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 101. INDIA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 102. INDIA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 103. INDIA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 104. AUSTRALIA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 105. AUSTRALIA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 106. AUSTRALIA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 107. AUSTRALIA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 108. AUSTRALIA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 109. SOUTH KOREA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 110. SOUTH KOREA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 111. SOUTH KOREA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 112. SOUTH KOREA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 113. SOUTH KOREA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 114. REST OF ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 115. REST OF ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 116. REST OF ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 117. REST OF ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 118. REST OF ASIA-PACIFIC CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 119. LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 120. LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 121. LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 122. LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 123. LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 124. LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 125. BRAZIL CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 126. BRAZIL CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 127. BRAZIL CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 128. BRAZIL CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 129. BRAZIL CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 130. SAUDI ARABIA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 131. SAUDI ARABIA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 132. SAUDI ARABIA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 133. SAUDI ARABIA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 134. SAUDI ARABIA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 135. SOUTH AFRICA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 136. SOUTH AFRICA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 137. SOUTH AFRICA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 138. SOUTH AFRICA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 139. SOUTH AFRICA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 140. REST OF LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE, 2024 - 2033 ($BILLION)
- TABLE 141. REST OF LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 142. REST OF LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
- TABLE 143. REST OF LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 144. REST OF LAMEA CUSTOM ANTIBODY SERVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 145. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
- TABLE 146. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- TABLE 147. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
- TABLE 148. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
- TABLE 149. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 150. MERCK KGAA: KEY EXECUTIVES
- TABLE 151. MERCK KGAA: COMPANY SNAPSHOT
- TABLE 152. MERCK KGAA: OPERATING SEGMENTS
- TABLE 153. MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 154. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 155. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
- TABLE 156. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- TABLE 157. AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
- TABLE 158. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
- TABLE 159. AGILENT TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 160. SINO BIOLOGICAL, INC.: KEY EXECUTIVES
- TABLE 161. SINO BIOLOGICAL, INC.: COMPANY SNAPSHOT
- TABLE 162. SINO BIOLOGICAL, INC.: OPERATING SEGMENTS
- TABLE 163. SINO BIOLOGICAL, INC.: PRODUCT PORTFOLIO
- TABLE 164. SINO BIOLOGICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 165. BIO-RAD LABORATORIES, INC: KEY EXECUTIVES
- TABLE 166. BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT
- TABLE 167. BIO-RAD LABORATORIES, INC: OPERATING SEGMENTS
- TABLE 168. BIO-RAD LABORATORIES, INC: PRODUCT PORTFOLIO
- TABLE 169. BIO-RAD LABORATORIES, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 170. KANEKA EUROGENTEC S.A.: KEY EXECUTIVES
- TABLE 171. KANEKA EUROGENTEC S.A.: COMPANY SNAPSHOT
- TABLE 172. KANEKA EUROGENTEC S.A.: OPERATING SEGMENTS
- TABLE 173. KANEKA EUROGENTEC S.A.: PRODUCT PORTFOLIO
- TABLE 174. KANE
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
